Advertisement

Index by author

July 01, 2002; Volume 62,Issue 1

A

  1. Ames, Matthew M.

    1. Activation of the Antitumor Agent Aminoflavone (NSC 686288) Is Mediated by Induction of Tumor Cell Cytochrome P450 1A1/1A2
      Mary J. Kuffel, Jennifer C. Schroeder, Lori J. Pobst, Stephen Naylor, Joel M. Reid, Scott H. Kaufmann and Matthew M. Ames
      Molecular Pharmacology July 2002, 62 (1) 143-153; DOI: https://doi.org/10.1124/mol.62.1.143

B

  1. Ballesteros, Juan A.

    1. Design, Synthesis and Pharmacological Evaluation of 5-Hydroxytryptamine1a Receptor Ligands to Explore the Three-Dimensional Structure of the Receptor
      Marı́a L. López-Rodrı́guez, Bruno Vicente, Xavier Deupi, Sergio Barrondo, Mireia Olivella, M. José Morcillo, Bellinda Behamú, Juan A. Ballesteros, Joan Sallés and Leonardo Pardo
      Molecular Pharmacology July 2002, 62 (1) 15-21; DOI: https://doi.org/10.1124/mol.62.1.15

  2. Barrondo, Sergio

    1. Design, Synthesis and Pharmacological Evaluation of 5-Hydroxytryptamine1a Receptor Ligands to Explore the Three-Dimensional Structure of the Receptor
      Marı́a L. López-Rodrı́guez, Bruno Vicente, Xavier Deupi, Sergio Barrondo, Mireia Olivella, M. José Morcillo, Bellinda Behamú, Juan A. Ballesteros, Joan Sallés and Leonardo Pardo
      Molecular Pharmacology July 2002, 62 (1) 15-21; DOI: https://doi.org/10.1124/mol.62.1.15

  3. Bayne, Marvin

    1. Molecular Modeling and Site-Specific Mutagenesis of the Histamine-Binding Site of the Histamine H4 Receptor
      Niu Shin, Elizabeth Coates, Nicholas J. Murgolo, Kelley L. Morse, Marvin Bayne, Catherine D. Strader and Frederick J. Monsma
      Molecular Pharmacology July 2002, 62 (1) 38-47; DOI: https://doi.org/10.1124/mol.62.1.38

  4. Behamú, Bellinda

    1. Design, Synthesis and Pharmacological Evaluation of 5-Hydroxytryptamine1a Receptor Ligands to Explore the Three-Dimensional Structure of the Receptor
      Marı́a L. López-Rodrı́guez, Bruno Vicente, Xavier Deupi, Sergio Barrondo, Mireia Olivella, M. José Morcillo, Bellinda Behamú, Juan A. Ballesteros, Joan Sallés and Leonardo Pardo
      Molecular Pharmacology July 2002, 62 (1) 15-21; DOI: https://doi.org/10.1124/mol.62.1.15

  5. Bender, Andrew T.

    1. Alteration of the Heme Prosthetic Group of Neuronal Nitric-Oxide Synthase during Inactivation byN G-Amino-l-arginine in Vitro and in Vivo
      Jennifer L. Vuletich, Ezra R. Lowe, Suree Jianmongkol, Yasuhiko Kamada, Ute M. Kent, Andrew T. Bender, Damon R. Demady, Paul F. Hollenberg and Yoichi Osawa
      Molecular Pharmacology July 2002, 62 (1) 110-118; DOI: https://doi.org/10.1124/mol.62.1.110

  6. Bomberger, J.

    1. Inhibition of Transforming Growth Factor (TGF)-β1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF-β Type I Receptor Kinase Activity: SB-431542
      N. J. Laping, E. Grygielko, A. Mathur, S. Butter, J. Bomberger, C. Tweed, W. Martin, J. Fornwald, R. Lehr, J. Harling, L. Gaster, J. F. Callahan and B. A. Olson
      Molecular Pharmacology July 2002, 62 (1) 58-64; DOI: https://doi.org/10.1124/mol.62.1.58

  7. Bousquet, Pascal

    1. [125I]2-(2-Chloro-4-iodo-phenylamino)-5-methyl-pyrroline (LNP 911), a High-Affinity Radioligand Selective for I1Imidazoline Receptors
      Hugues Greney, Dragan Urosevic, Stephan Schann, Laurence Dupuy, Véronique Bruban, Jean-Daniel Ehrhardt, Pascal Bousquet and Monique Dontenwill
      Molecular Pharmacology July 2002, 62 (1) 181-191; DOI: https://doi.org/10.1124/mol.62.1.181

  8. Bruban, Véronique

    1. [125I]2-(2-Chloro-4-iodo-phenylamino)-5-methyl-pyrroline (LNP 911), a High-Affinity Radioligand Selective for I1Imidazoline Receptors
      Hugues Greney, Dragan Urosevic, Stephan Schann, Laurence Dupuy, Véronique Bruban, Jean-Daniel Ehrhardt, Pascal Bousquet and Monique Dontenwill
      Molecular Pharmacology July 2002, 62 (1) 181-191; DOI: https://doi.org/10.1124/mol.62.1.181

  9. Butter, S.

    1. Inhibition of Transforming Growth Factor (TGF)-β1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF-β Type I Receptor Kinase Activity: SB-431542
      N. J. Laping, E. Grygielko, A. Mathur, S. Butter, J. Bomberger, C. Tweed, W. Martin, J. Fornwald, R. Lehr, J. Harling, L. Gaster, J. F. Callahan and B. A. Olson
      Molecular Pharmacology July 2002, 62 (1) 58-64; DOI: https://doi.org/10.1124/mol.62.1.58

C

  1. Callahan, J. F.

    1. Inhibition of Transforming Growth Factor (TGF)-β1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF-β Type I Receptor Kinase Activity: SB-431542
      N. J. Laping, E. Grygielko, A. Mathur, S. Butter, J. Bomberger, C. Tweed, W. Martin, J. Fornwald, R. Lehr, J. Harling, L. Gaster, J. F. Callahan and B. A. Olson
      Molecular Pharmacology July 2002, 62 (1) 58-64; DOI: https://doi.org/10.1124/mol.62.1.58

  2. Callahan, James F.

    1. SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
      Gareth J. Inman, Francisco J. Nicolás, James F. Callahan, John D. Harling, Laramie M. Gaster, Alastair D. Reith, Nicholas J. Laping and Caroline S. Hill
      Molecular Pharmacology July 2002, 62 (1) 65-74; DOI: https://doi.org/10.1124/mol.62.1.65

  3. Célérier, Marie-Louise

    1. Novel Tarantula Toxins for Subtypes of Voltage-Dependent Potassium Channels in the Kv2 and Kv4 Subfamilies
      Pierre Escoubas, Sylvie Diochot, Marie-Louise Célérier, Terumi Nakajima and Michel Lazdunski
      Molecular Pharmacology July 2002, 62 (1) 48-57; DOI: https://doi.org/10.1124/mol.62.1.48

  4. Chao, Yee

    1. Aurintricarboxylic Acid Protects against Cell Death Caused by Lipopolysaccharide in Macrophages by Decreasing Inducible Nitric-Oxide Synthase Induction via IκB Kinase, Extracellular Signal-Regulated Kinase, and p38 Mitogen-Activated Protein Kinase Inhibition
      Chin-Ju Tsi, Yee Chao, Ching-Wen Chen and Wan Wan Lin
      Molecular Pharmacology July 2002, 62 (1) 90-101; DOI: https://doi.org/10.1124/mol.62.1.90

  5. Chen, Ching-Wen

    1. Aurintricarboxylic Acid Protects against Cell Death Caused by Lipopolysaccharide in Macrophages by Decreasing Inducible Nitric-Oxide Synthase Induction via IκB Kinase, Extracellular Signal-Regulated Kinase, and p38 Mitogen-Activated Protein Kinase Inhibition
      Chin-Ju Tsi, Yee Chao, Ching-Wen Chen and Wan Wan Lin
      Molecular Pharmacology July 2002, 62 (1) 90-101; DOI: https://doi.org/10.1124/mol.62.1.90

  6. Coates, Elizabeth

    1. Molecular Modeling and Site-Specific Mutagenesis of the Histamine-Binding Site of the Histamine H4 Receptor
      Niu Shin, Elizabeth Coates, Nicholas J. Murgolo, Kelley L. Morse, Marvin Bayne, Catherine D. Strader and Frederick J. Monsma
      Molecular Pharmacology July 2002, 62 (1) 38-47; DOI: https://doi.org/10.1124/mol.62.1.38

  7. Coulthard, Sally A.

    1. The Effect of Thiopurine Methyltransferase Expression on Sensitivity to Thiopurine Drugs
      Sally A. Coulthard, Linda A. Hogarth, Margaret Little, Elizabeth C. Matheson, Christopher P. F. Redfern, Lynne Minto and Andrew G. Hall
      Molecular Pharmacology July 2002, 62 (1) 102-109; DOI: https://doi.org/10.1124/mol.62.1.102

D

  1. Dayanithi, Govindan

    1. Integrated Channel Plasticity Contributes to Alcohol Tolerance in Neurohypophysial Terminals
      Thomas K. Knott, Alejandro M. Dopico, Govindan Dayanithi, José Lemos and Steven N. Treistman
      Molecular Pharmacology July 2002, 62 (1) 135-142; DOI: https://doi.org/10.1124/mol.62.1.135

  2. Demady, Damon R.

    1. Alteration of the Heme Prosthetic Group of Neuronal Nitric-Oxide Synthase during Inactivation byN G-Amino-l-arginine in Vitro and in Vivo
      Jennifer L. Vuletich, Ezra R. Lowe, Suree Jianmongkol, Yasuhiko Kamada, Ute M. Kent, Andrew T. Bender, Damon R. Demady, Paul F. Hollenberg and Yoichi Osawa
      Molecular Pharmacology July 2002, 62 (1) 110-118; DOI: https://doi.org/10.1124/mol.62.1.110

  3. Deupi, Xavier

    1. Design, Synthesis and Pharmacological Evaluation of 5-Hydroxytryptamine1a Receptor Ligands to Explore the Three-Dimensional Structure of the Receptor
      Marı́a L. López-Rodrı́guez, Bruno Vicente, Xavier Deupi, Sergio Barrondo, Mireia Olivella, M. José Morcillo, Bellinda Behamú, Juan A. Ballesteros, Joan Sallés and Leonardo Pardo
      Molecular Pharmacology July 2002, 62 (1) 15-21; DOI: https://doi.org/10.1124/mol.62.1.15

  4. Diochot, Sylvie

    1. Novel Tarantula Toxins for Subtypes of Voltage-Dependent Potassium Channels in the Kv2 and Kv4 Subfamilies
      Pierre Escoubas, Sylvie Diochot, Marie-Louise Célérier, Terumi Nakajima and Michel Lazdunski
      Molecular Pharmacology July 2002, 62 (1) 48-57; DOI: https://doi.org/10.1124/mol.62.1.48

  5. Dontenwill, Monique

    1. [125I]2-(2-Chloro-4-iodo-phenylamino)-5-methyl-pyrroline (LNP 911), a High-Affinity Radioligand Selective for I1Imidazoline Receptors
      Hugues Greney, Dragan Urosevic, Stephan Schann, Laurence Dupuy, Véronique Bruban, Jean-Daniel Ehrhardt, Pascal Bousquet and Monique Dontenwill
      Molecular Pharmacology July 2002, 62 (1) 181-191; DOI: https://doi.org/10.1124/mol.62.1.181

  6. Dopico, Alejandro M.

    1. Integrated Channel Plasticity Contributes to Alcohol Tolerance in Neurohypophysial Terminals
      Thomas K. Knott, Alejandro M. Dopico, Govindan Dayanithi, José Lemos and Steven N. Treistman
      Molecular Pharmacology July 2002, 62 (1) 135-142; DOI: https://doi.org/10.1124/mol.62.1.135

  7. Dowling, Amy L. S.

    1. Co-Regulation of CYP3A4 and CYP3A5 and Contribution to Hepatic and Intestinal Midazolam Metabolism
      Yvonne S. Lin, Amy L. S. Dowling, Sean D. Quigley, Federico M. Farin, Jiong Zhang, Jatinder Lamba, Erin G. Schuetz and Kenneth E. Thummel
      Molecular Pharmacology July 2002, 62 (1) 162-172; DOI: https://doi.org/10.1124/mol.62.1.162

  8. Dupuy, Laurence

    1. [125I]2-(2-Chloro-4-iodo-phenylamino)-5-methyl-pyrroline (LNP 911), a High-Affinity Radioligand Selective for I1Imidazoline Receptors
      Hugues Greney, Dragan Urosevic, Stephan Schann, Laurence Dupuy, Véronique Bruban, Jean-Daniel Ehrhardt, Pascal Bousquet and Monique Dontenwill
      Molecular Pharmacology July 2002, 62 (1) 181-191; DOI: https://doi.org/10.1124/mol.62.1.181

E

  1. Ehrhardt, Jean-Daniel

    1. [125I]2-(2-Chloro-4-iodo-phenylamino)-5-methyl-pyrroline (LNP 911), a High-Affinity Radioligand Selective for I1Imidazoline Receptors
      Hugues Greney, Dragan Urosevic, Stephan Schann, Laurence Dupuy, Véronique Bruban, Jean-Daniel Ehrhardt, Pascal Bousquet and Monique Dontenwill
      Molecular Pharmacology July 2002, 62 (1) 181-191; DOI: https://doi.org/10.1124/mol.62.1.181

  2. Endou, Hitoshi

    1. Isolation, Characterization and Differential Gene Expression of Multispecific Organic Anion Transporter 2 in Mice
      Yasuna Kobayashi, Naomi Ohshiro, Akiko Shibusawa, Tadanori Sasaki, Shogo Tokuyama, Takashi Sekine, Hitoshi Endou and Toshinori Yamamoto
      Molecular Pharmacology July 2002, 62 (1) 7-14; DOI: https://doi.org/10.1124/mol.62.1.7

  3. Escoubas, Pierre

    1. Novel Tarantula Toxins for Subtypes of Voltage-Dependent Potassium Channels in the Kv2 and Kv4 Subfamilies
      Pierre Escoubas, Sylvie Diochot, Marie-Louise Célérier, Terumi Nakajima and Michel Lazdunski
      Molecular Pharmacology July 2002, 62 (1) 48-57; DOI: https://doi.org/10.1124/mol.62.1.48

F

  1. Farin, Federico M.

    1. Co-Regulation of CYP3A4 and CYP3A5 and Contribution to Hepatic and Intestinal Midazolam Metabolism
      Yvonne S. Lin, Amy L. S. Dowling, Sean D. Quigley, Federico M. Farin, Jiong Zhang, Jatinder Lamba, Erin G. Schuetz and Kenneth E. Thummel
      Molecular Pharmacology July 2002, 62 (1) 162-172; DOI: https://doi.org/10.1124/mol.62.1.162

  2. Feldtrauer, Jean-Jacques

    1. Inhibition of the Mitochondrial Permeability Transition by the Nonimmunosuppressive Cyclosporin Derivative NIM811
      Peter C. Waldmeier, Jean-Jacques Feldtrauer, Ting Qian and John J. Lemasters
      Molecular Pharmacology July 2002, 62 (1) 22-29; DOI: https://doi.org/10.1124/mol.62.1.22

  3. Fornwald, J.

    1. Inhibition of Transforming Growth Factor (TGF)-β1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF-β Type I Receptor Kinase Activity: SB-431542
      N. J. Laping, E. Grygielko, A. Mathur, S. Butter, J. Bomberger, C. Tweed, W. Martin, J. Fornwald, R. Lehr, J. Harling, L. Gaster, J. F. Callahan and B. A. Olson
      Molecular Pharmacology July 2002, 62 (1) 58-64; DOI: https://doi.org/10.1124/mol.62.1.58

  4. Fraile-Ramos, Alberto

    1. NK1 Receptor Fused to β-Arrestin Displays a Single-Component, High-Affinity Molecular Phenotype
      Lene Martini, Hanne Hastrup, Birgitte Holst, Alberto Fraile-Ramos, Mark Marsh and Thue W. Schwartz
      Molecular Pharmacology July 2002, 62 (1) 30-37; DOI: https://doi.org/10.1124/mol.62.1.30

G

  1. Gao, Zhan-Guo

    1. Selective Allosteric Enhancement of Agonist Binding and Function at Human A3 Adenosine Receptors by a Series of Imidazoquinoline Derivatives
      Zhan-Guo Gao, Seong Gon Kim, Kelly A. Soltysiak, Neli Melman, Adriaan P. IJzerman and Kenneth A. Jacobson
      Molecular Pharmacology July 2002, 62 (1) 81-89; DOI: https://doi.org/10.1124/mol.62.1.81

  2. Gaster, L.

    1. Inhibition of Transforming Growth Factor (TGF)-β1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF-β Type I Receptor Kinase Activity: SB-431542
      N. J. Laping, E. Grygielko, A. Mathur, S. Butter, J. Bomberger, C. Tweed, W. Martin, J. Fornwald, R. Lehr, J. Harling, L. Gaster, J. F. Callahan and B. A. Olson
      Molecular Pharmacology July 2002, 62 (1) 58-64; DOI: https://doi.org/10.1124/mol.62.1.58

  3. Gaster, Laramie M.

    1. SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
      Gareth J. Inman, Francisco J. Nicolás, James F. Callahan, John D. Harling, Laramie M. Gaster, Alastair D. Reith, Nicholas J. Laping and Caroline S. Hill
      Molecular Pharmacology July 2002, 62 (1) 65-74; DOI: https://doi.org/10.1124/mol.62.1.65

  4. Gottesman, Michael M.

    1. Functional Characterization of Coding Polymorphisms in the HumanMDR1 Gene Using a Vaccinia Virus Expression System
      Chava Kimchi-Sarfaty, John J. Gribar and Michael M. Gottesman
      Molecular Pharmacology July 2002, 62 (1) 1-6; DOI: https://doi.org/10.1124/mol.62.1.1

  5. Gouwy, Mieke

    1. The Unique Property of the CC Chemokine Regakine-1 to Synergize with Other Plasma-Derived Inflammatory Mediators in Neutrophil Chemotaxis Does Not Reside in Its NH2-Terminal Structure
      Mieke Gouwy, Sofie Struyf, Frank Mahieu, Willy Put, Paul Proost and Jo Van Damme
      Molecular Pharmacology July 2002, 62 (1) 173-180; DOI: https://doi.org/10.1124/mol.62.1.173

  6. Gregory, Philip A.

    1. The Homeodomain Pbx2-Prep1 Complex Modulates Hepatocyte Nuclear Factor 1α-Mediated Activation of theUDP-Glucuronosyltransferase 2B17 Gene
      Philip A. Gregory and Peter I. Mackenzie
      Molecular Pharmacology July 2002, 62 (1) 154-161; DOI: https://doi.org/10.1124/mol.62.1.154

  7. Greney, Hugues

    1. [125I]2-(2-Chloro-4-iodo-phenylamino)-5-methyl-pyrroline (LNP 911), a High-Affinity Radioligand Selective for I1Imidazoline Receptors
      Hugues Greney, Dragan Urosevic, Stephan Schann, Laurence Dupuy, Véronique Bruban, Jean-Daniel Ehrhardt, Pascal Bousquet and Monique Dontenwill
      Molecular Pharmacology July 2002, 62 (1) 181-191; DOI: https://doi.org/10.1124/mol.62.1.181

  8. Gribar, John J.

    1. Functional Characterization of Coding Polymorphisms in the HumanMDR1 Gene Using a Vaccinia Virus Expression System
      Chava Kimchi-Sarfaty, John J. Gribar and Michael M. Gottesman
      Molecular Pharmacology July 2002, 62 (1) 1-6; DOI: https://doi.org/10.1124/mol.62.1.1

  9. Grygielko, E.

    1. Inhibition of Transforming Growth Factor (TGF)-β1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF-β Type I Receptor Kinase Activity: SB-431542
      N. J. Laping, E. Grygielko, A. Mathur, S. Butter, J. Bomberger, C. Tweed, W. Martin, J. Fornwald, R. Lehr, J. Harling, L. Gaster, J. F. Callahan and B. A. Olson
      Molecular Pharmacology July 2002, 62 (1) 58-64; DOI: https://doi.org/10.1124/mol.62.1.58

H

  1. Hall, Andrew G.

    1. The Effect of Thiopurine Methyltransferase Expression on Sensitivity to Thiopurine Drugs
      Sally A. Coulthard, Linda A. Hogarth, Margaret Little, Elizabeth C. Matheson, Christopher P. F. Redfern, Lynne Minto and Andrew G. Hall
      Molecular Pharmacology July 2002, 62 (1) 102-109; DOI: https://doi.org/10.1124/mol.62.1.102

  2. Harling, J.

    1. Inhibition of Transforming Growth Factor (TGF)-β1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF-β Type I Receptor Kinase Activity: SB-431542
      N. J. Laping, E. Grygielko, A. Mathur, S. Butter, J. Bomberger, C. Tweed, W. Martin, J. Fornwald, R. Lehr, J. Harling, L. Gaster, J. F. Callahan and B. A. Olson
      Molecular Pharmacology July 2002, 62 (1) 58-64; DOI: https://doi.org/10.1124/mol.62.1.58

  3. Harling, John D.

    1. SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
      Gareth J. Inman, Francisco J. Nicolás, James F. Callahan, John D. Harling, Laramie M. Gaster, Alastair D. Reith, Nicholas J. Laping and Caroline S. Hill
      Molecular Pharmacology July 2002, 62 (1) 65-74; DOI: https://doi.org/10.1124/mol.62.1.65

  4. Hashimoto, Nobuo

    1. Molecular Mechanisms for the Activation of Voltage-Independent Ca2+ Channels by Endothelin-1 in Chinese Hamster Ovary Cells Stably Expressing Human EndothelinA Receptors
      Yoshifumi Kawanabe, Yasuo Okamoto, Soichi Miwa, Nobuo Hashimoto and Tomoh Masaki
      Molecular Pharmacology July 2002, 62 (1) 75-80; DOI: https://doi.org/10.1124/mol.62.1.75

  5. Hastrup, Hanne

    1. NK1 Receptor Fused to β-Arrestin Displays a Single-Component, High-Affinity Molecular Phenotype
      Lene Martini, Hanne Hastrup, Birgitte Holst, Alberto Fraile-Ramos, Mark Marsh and Thue W. Schwartz
      Molecular Pharmacology July 2002, 62 (1) 30-37; DOI: https://doi.org/10.1124/mol.62.1.30

  6. Hill, Caroline S.

    1. SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
      Gareth J. Inman, Francisco J. Nicolás, James F. Callahan, John D. Harling, Laramie M. Gaster, Alastair D. Reith, Nicholas J. Laping and Caroline S. Hill
      Molecular Pharmacology July 2002, 62 (1) 65-74; DOI: https://doi.org/10.1124/mol.62.1.65

  7. Hogarth, Linda A.

    1. The Effect of Thiopurine Methyltransferase Expression on Sensitivity to Thiopurine Drugs
      Sally A. Coulthard, Linda A. Hogarth, Margaret Little, Elizabeth C. Matheson, Christopher P. F. Redfern, Lynne Minto and Andrew G. Hall
      Molecular Pharmacology July 2002, 62 (1) 102-109; DOI: https://doi.org/10.1124/mol.62.1.102

  8. Hollenberg, Paul F.

    1. Alteration of the Heme Prosthetic Group of Neuronal Nitric-Oxide Synthase during Inactivation byN G-Amino-l-arginine in Vitro and in Vivo
      Jennifer L. Vuletich, Ezra R. Lowe, Suree Jianmongkol, Yasuhiko Kamada, Ute M. Kent, Andrew T. Bender, Damon R. Demady, Paul F. Hollenberg and Yoichi Osawa
      Molecular Pharmacology July 2002, 62 (1) 110-118; DOI: https://doi.org/10.1124/mol.62.1.110

  9. Holst, Birgitte

    1. NK1 Receptor Fused to β-Arrestin Displays a Single-Component, High-Affinity Molecular Phenotype
      Lene Martini, Hanne Hastrup, Birgitte Holst, Alberto Fraile-Ramos, Mark Marsh and Thue W. Schwartz
      Molecular Pharmacology July 2002, 62 (1) 30-37; DOI: https://doi.org/10.1124/mol.62.1.30

  10. Hoshi, Toshinori

    1. Molecular Determinants of Intracellular pH Modulation of Human Kv1.4 N-Type Inactivation
      Benzy J. Padanilam, Tong Lu, Toshinori Hoshi, Beena A. Padanilam, Erwin F. Shibata and Hon-Chi Lee
      Molecular Pharmacology July 2002, 62 (1) 127-134; DOI: https://doi.org/10.1124/mol.62.1.127

I

  1. IJzerman, Adriaan P.

    1. Selective Allosteric Enhancement of Agonist Binding and Function at Human A3 Adenosine Receptors by a Series of Imidazoquinoline Derivatives
      Zhan-Guo Gao, Seong Gon Kim, Kelly A. Soltysiak, Neli Melman, Adriaan P. IJzerman and Kenneth A. Jacobson
      Molecular Pharmacology July 2002, 62 (1) 81-89; DOI: https://doi.org/10.1124/mol.62.1.81

  2. Inman, Gareth J.

    1. SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
      Gareth J. Inman, Francisco J. Nicolás, James F. Callahan, John D. Harling, Laramie M. Gaster, Alastair D. Reith, Nicholas J. Laping and Caroline S. Hill
      Molecular Pharmacology July 2002, 62 (1) 65-74; DOI: https://doi.org/10.1124/mol.62.1.65

J

  1. Jacobson, Kenneth A.

    1. Selective Allosteric Enhancement of Agonist Binding and Function at Human A3 Adenosine Receptors by a Series of Imidazoquinoline Derivatives
      Zhan-Guo Gao, Seong Gon Kim, Kelly A. Soltysiak, Neli Melman, Adriaan P. IJzerman and Kenneth A. Jacobson
      Molecular Pharmacology July 2002, 62 (1) 81-89; DOI: https://doi.org/10.1124/mol.62.1.81

  2. Jianmongkol, Suree

    1. Alteration of the Heme Prosthetic Group of Neuronal Nitric-Oxide Synthase during Inactivation byN G-Amino-l-arginine in Vitro and in Vivo
      Jennifer L. Vuletich, Ezra R. Lowe, Suree Jianmongkol, Yasuhiko Kamada, Ute M. Kent, Andrew T. Bender, Damon R. Demady, Paul F. Hollenberg and Yoichi Osawa
      Molecular Pharmacology July 2002, 62 (1) 110-118; DOI: https://doi.org/10.1124/mol.62.1.110

K

  1. Kamada, Yasuhiko

    1. Alteration of the Heme Prosthetic Group of Neuronal Nitric-Oxide Synthase during Inactivation byN G-Amino-l-arginine in Vitro and in Vivo
      Jennifer L. Vuletich, Ezra R. Lowe, Suree Jianmongkol, Yasuhiko Kamada, Ute M. Kent, Andrew T. Bender, Damon R. Demady, Paul F. Hollenberg and Yoichi Osawa
      Molecular Pharmacology July 2002, 62 (1) 110-118; DOI: https://doi.org/10.1124/mol.62.1.110

  2. Kaufmann, Scott H.

    1. Activation of the Antitumor Agent Aminoflavone (NSC 686288) Is Mediated by Induction of Tumor Cell Cytochrome P450 1A1/1A2
      Mary J. Kuffel, Jennifer C. Schroeder, Lori J. Pobst, Stephen Naylor, Joel M. Reid, Scott H. Kaufmann and Matthew M. Ames
      Molecular Pharmacology July 2002, 62 (1) 143-153; DOI: https://doi.org/10.1124/mol.62.1.143

  3. Kawanabe, Yoshifumi

    1. Molecular Mechanisms for the Activation of Voltage-Independent Ca2+ Channels by Endothelin-1 in Chinese Hamster Ovary Cells Stably Expressing Human EndothelinA Receptors
      Yoshifumi Kawanabe, Yasuo Okamoto, Soichi Miwa, Nobuo Hashimoto and Tomoh Masaki
      Molecular Pharmacology July 2002, 62 (1) 75-80; DOI: https://doi.org/10.1124/mol.62.1.75

  4. Kent, Ute M.

    1. Alteration of the Heme Prosthetic Group of Neuronal Nitric-Oxide Synthase during Inactivation byN G-Amino-l-arginine in Vitro and in Vivo
      Jennifer L. Vuletich, Ezra R. Lowe, Suree Jianmongkol, Yasuhiko Kamada, Ute M. Kent, Andrew T. Bender, Damon R. Demady, Paul F. Hollenberg and Yoichi Osawa
      Molecular Pharmacology July 2002, 62 (1) 110-118; DOI: https://doi.org/10.1124/mol.62.1.110

  5. Kim, Seong Gon

    1. Selective Allosteric Enhancement of Agonist Binding and Function at Human A3 Adenosine Receptors by a Series of Imidazoquinoline Derivatives
      Zhan-Guo Gao, Seong Gon Kim, Kelly A. Soltysiak, Neli Melman, Adriaan P. IJzerman and Kenneth A. Jacobson
      Molecular Pharmacology July 2002, 62 (1) 81-89; DOI: https://doi.org/10.1124/mol.62.1.81

  6. Kimchi-Sarfaty, Chava

    1. Functional Characterization of Coding Polymorphisms in the HumanMDR1 Gene Using a Vaccinia Virus Expression System
      Chava Kimchi-Sarfaty, John J. Gribar and Michael M. Gottesman
      Molecular Pharmacology July 2002, 62 (1) 1-6; DOI: https://doi.org/10.1124/mol.62.1.1

  7. Knott, Thomas K.

    1. Integrated Channel Plasticity Contributes to Alcohol Tolerance in Neurohypophysial Terminals
      Thomas K. Knott, Alejandro M. Dopico, Govindan Dayanithi, José Lemos and Steven N. Treistman
      Molecular Pharmacology July 2002, 62 (1) 135-142; DOI: https://doi.org/10.1124/mol.62.1.135

  8. Kobayashi, Yasuna

    1. Isolation, Characterization and Differential Gene Expression of Multispecific Organic Anion Transporter 2 in Mice
      Yasuna Kobayashi, Naomi Ohshiro, Akiko Shibusawa, Tadanori Sasaki, Shogo Tokuyama, Takashi Sekine, Hitoshi Endou and Toshinori Yamamoto
      Molecular Pharmacology July 2002, 62 (1) 7-14; DOI: https://doi.org/10.1124/mol.62.1.7

  9. Kuffel, Mary J.

    1. Activation of the Antitumor Agent Aminoflavone (NSC 686288) Is Mediated by Induction of Tumor Cell Cytochrome P450 1A1/1A2
      Mary J. Kuffel, Jennifer C. Schroeder, Lori J. Pobst, Stephen Naylor, Joel M. Reid, Scott H. Kaufmann and Matthew M. Ames
      Molecular Pharmacology July 2002, 62 (1) 143-153; DOI: https://doi.org/10.1124/mol.62.1.143

  10. Kuzhikandathil, Eldo V.

    1. Classic D1 Dopamine Receptor AntagonistR-(+)-7-Chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride (SCH23390) Directly Inhibits G Protein-Coupled Inwardly Rectifying Potassium Channels
      Eldo V. Kuzhikandathil and Gerry S. Oxford
      Molecular Pharmacology July 2002, 62 (1) 119-126; DOI: https://doi.org/10.1124/mol.62.1.119

L

  1. Lamba, Jatinder

    1. Co-Regulation of CYP3A4 and CYP3A5 and Contribution to Hepatic and Intestinal Midazolam Metabolism
      Yvonne S. Lin, Amy L. S. Dowling, Sean D. Quigley, Federico M. Farin, Jiong Zhang, Jatinder Lamba, Erin G. Schuetz and Kenneth E. Thummel
      Molecular Pharmacology July 2002, 62 (1) 162-172; DOI: https://doi.org/10.1124/mol.62.1.162

  2. Laping, N. J.

    1. Inhibition of Transforming Growth Factor (TGF)-β1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF-β Type I Receptor Kinase Activity: SB-431542
      N. J. Laping, E. Grygielko, A. Mathur, S. Butter, J. Bomberger, C. Tweed, W. Martin, J. Fornwald, R. Lehr, J. Harling, L. Gaster, J. F. Callahan and B. A. Olson
      Molecular Pharmacology July 2002, 62 (1) 58-64; DOI: https://doi.org/10.1124/mol.62.1.58

  3. Laping, Nicholas J.

    1. SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
      Gareth J. Inman, Francisco J. Nicolás, James F. Callahan, John D. Harling, Laramie M. Gaster, Alastair D. Reith, Nicholas J. Laping and Caroline S. Hill
      Molecular Pharmacology July 2002, 62 (1) 65-74; DOI: https://doi.org/10.1124/mol.62.1.65

  4. Lazdunski, Michel

    1. Novel Tarantula Toxins for Subtypes of Voltage-Dependent Potassium Channels in the Kv2 and Kv4 Subfamilies
      Pierre Escoubas, Sylvie Diochot, Marie-Louise Célérier, Terumi Nakajima and Michel Lazdunski
      Molecular Pharmacology July 2002, 62 (1) 48-57; DOI: https://doi.org/10.1124/mol.62.1.48

  5. Lee, Hon-Chi

    1. Molecular Determinants of Intracellular pH Modulation of Human Kv1.4 N-Type Inactivation
      Benzy J. Padanilam, Tong Lu, Toshinori Hoshi, Beena A. Padanilam, Erwin F. Shibata and Hon-Chi Lee
      Molecular Pharmacology July 2002, 62 (1) 127-134; DOI: https://doi.org/10.1124/mol.62.1.127

  6. Lehr, R.

    1. Inhibition of Transforming Growth Factor (TGF)-β1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF-β Type I Receptor Kinase Activity: SB-431542
      N. J. Laping, E. Grygielko, A. Mathur, S. Butter, J. Bomberger, C. Tweed, W. Martin, J. Fornwald, R. Lehr, J. Harling, L. Gaster, J. F. Callahan and B. A. Olson
      Molecular Pharmacology July 2002, 62 (1) 58-64; DOI: https://doi.org/10.1124/mol.62.1.58

  7. Lemasters, John J.

    1. Inhibition of the Mitochondrial Permeability Transition by the Nonimmunosuppressive Cyclosporin Derivative NIM811
      Peter C. Waldmeier, Jean-Jacques Feldtrauer, Ting Qian and John J. Lemasters
      Molecular Pharmacology July 2002, 62 (1) 22-29; DOI: https://doi.org/10.1124/mol.62.1.22

  8. Lemos, José

    1. Integrated Channel Plasticity Contributes to Alcohol Tolerance in Neurohypophysial Terminals
      Thomas K. Knott, Alejandro M. Dopico, Govindan Dayanithi, José Lemos and Steven N. Treistman
      Molecular Pharmacology July 2002, 62 (1) 135-142; DOI: https://doi.org/10.1124/mol.62.1.135

  9. Lin, Wan Wan

    1. Aurintricarboxylic Acid Protects against Cell Death Caused by Lipopolysaccharide in Macrophages by Decreasing Inducible Nitric-Oxide Synthase Induction via IκB Kinase, Extracellular Signal-Regulated Kinase, and p38 Mitogen-Activated Protein Kinase Inhibition
      Chin-Ju Tsi, Yee Chao, Ching-Wen Chen and Wan Wan Lin
      Molecular Pharmacology July 2002, 62 (1) 90-101; DOI: https://doi.org/10.1124/mol.62.1.90

  10. Lin, Yvonne S.

    1. Co-Regulation of CYP3A4 and CYP3A5 and Contribution to Hepatic and Intestinal Midazolam Metabolism
      Yvonne S. Lin, Amy L. S. Dowling, Sean D. Quigley, Federico M. Farin, Jiong Zhang, Jatinder Lamba, Erin G. Schuetz and Kenneth E. Thummel
      Molecular Pharmacology July 2002, 62 (1) 162-172; DOI: https://doi.org/10.1124/mol.62.1.162

  11. Little, Margaret

    1. The Effect of Thiopurine Methyltransferase Expression on Sensitivity to Thiopurine Drugs
      Sally A. Coulthard, Linda A. Hogarth, Margaret Little, Elizabeth C. Matheson, Christopher P. F. Redfern, Lynne Minto and Andrew G. Hall
      Molecular Pharmacology July 2002, 62 (1) 102-109; DOI: https://doi.org/10.1124/mol.62.1.102

  12. López-Rodrı́guez, Marı́a L.

    1. Design, Synthesis and Pharmacological Evaluation of 5-Hydroxytryptamine1a Receptor Ligands to Explore the Three-Dimensional Structure of the Receptor
      Marı́a L. López-Rodrı́guez, Bruno Vicente, Xavier Deupi, Sergio Barrondo, Mireia Olivella, M. José Morcillo, Bellinda Behamú, Juan A. Ballesteros, Joan Sallés and Leonardo Pardo
      Molecular Pharmacology July 2002, 62 (1) 15-21; DOI: https://doi.org/10.1124/mol.62.1.15

  13. Lowe, Ezra R.

    1. Alteration of the Heme Prosthetic Group of Neuronal Nitric-Oxide Synthase during Inactivation byN G-Amino-l-arginine in Vitro and in Vivo
      Jennifer L. Vuletich, Ezra R. Lowe, Suree Jianmongkol, Yasuhiko Kamada, Ute M. Kent, Andrew T. Bender, Damon R. Demady, Paul F. Hollenberg and Yoichi Osawa
      Molecular Pharmacology July 2002, 62 (1) 110-118; DOI: https://doi.org/10.1124/mol.62.1.110

  14. Lu, Tong

    1. Molecular Determinants of Intracellular pH Modulation of Human Kv1.4 N-Type Inactivation
      Benzy J. Padanilam, Tong Lu, Toshinori Hoshi, Beena A. Padanilam, Erwin F. Shibata and Hon-Chi Lee
      Molecular Pharmacology July 2002, 62 (1) 127-134; DOI: https://doi.org/10.1124/mol.62.1.127

M

  1. Mackenzie, Peter I.

    1. The Homeodomain Pbx2-Prep1 Complex Modulates Hepatocyte Nuclear Factor 1α-Mediated Activation of theUDP-Glucuronosyltransferase 2B17 Gene
      Philip A. Gregory and Peter I. Mackenzie
      Molecular Pharmacology July 2002, 62 (1) 154-161; DOI: https://doi.org/10.1124/mol.62.1.154

  2. Mahieu, Frank

    1. The Unique Property of the CC Chemokine Regakine-1 to Synergize with Other Plasma-Derived Inflammatory Mediators in Neutrophil Chemotaxis Does Not Reside in Its NH2-Terminal Structure
      Mieke Gouwy, Sofie Struyf, Frank Mahieu, Willy Put, Paul Proost and Jo Van Damme
      Molecular Pharmacology July 2002, 62 (1) 173-180; DOI: https://doi.org/10.1124/mol.62.1.173

  3. Marsh, Mark

    1. NK1 Receptor Fused to β-Arrestin Displays a Single-Component, High-Affinity Molecular Phenotype
      Lene Martini, Hanne Hastrup, Birgitte Holst, Alberto Fraile-Ramos, Mark Marsh and Thue W. Schwartz
      Molecular Pharmacology July 2002, 62 (1) 30-37; DOI: https://doi.org/10.1124/mol.62.1.30

  4. Martin, W.

    1. Inhibition of Transforming Growth Factor (TGF)-β1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF-β Type I Receptor Kinase Activity: SB-431542
      N. J. Laping, E. Grygielko, A. Mathur, S. Butter, J. Bomberger, C. Tweed, W. Martin, J. Fornwald, R. Lehr, J. Harling, L. Gaster, J. F. Callahan and B. A. Olson
      Molecular Pharmacology July 2002, 62 (1) 58-64; DOI: https://doi.org/10.1124/mol.62.1.58

  5. Martini, Lene

    1. NK1 Receptor Fused to β-Arrestin Displays a Single-Component, High-Affinity Molecular Phenotype
      Lene Martini, Hanne Hastrup, Birgitte Holst, Alberto Fraile-Ramos, Mark Marsh and Thue W. Schwartz
      Molecular Pharmacology July 2002, 62 (1) 30-37; DOI: https://doi.org/10.1124/mol.62.1.30

  6. Masaki, Tomoh

    1. Molecular Mechanisms for the Activation of Voltage-Independent Ca2+ Channels by Endothelin-1 in Chinese Hamster Ovary Cells Stably Expressing Human EndothelinA Receptors
      Yoshifumi Kawanabe, Yasuo Okamoto, Soichi Miwa, Nobuo Hashimoto and Tomoh Masaki
      Molecular Pharmacology July 2002, 62 (1) 75-80; DOI: https://doi.org/10.1124/mol.62.1.75

  7. Matheson, Elizabeth C.

    1. The Effect of Thiopurine Methyltransferase Expression on Sensitivity to Thiopurine Drugs
      Sally A. Coulthard, Linda A. Hogarth, Margaret Little, Elizabeth C. Matheson, Christopher P. F. Redfern, Lynne Minto and Andrew G. Hall
      Molecular Pharmacology July 2002, 62 (1) 102-109; DOI: https://doi.org/10.1124/mol.62.1.102

  8. Mathur, A.

    1. Inhibition of Transforming Growth Factor (TGF)-β1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF-β Type I Receptor Kinase Activity: SB-431542
      N. J. Laping, E. Grygielko, A. Mathur, S. Butter, J. Bomberger, C. Tweed, W. Martin, J. Fornwald, R. Lehr, J. Harling, L. Gaster, J. F. Callahan and B. A. Olson
      Molecular Pharmacology July 2002, 62 (1) 58-64; DOI: https://doi.org/10.1124/mol.62.1.58

  9. Melman, Neli

    1. Selective Allosteric Enhancement of Agonist Binding and Function at Human A3 Adenosine Receptors by a Series of Imidazoquinoline Derivatives
      Zhan-Guo Gao, Seong Gon Kim, Kelly A. Soltysiak, Neli Melman, Adriaan P. IJzerman and Kenneth A. Jacobson
      Molecular Pharmacology July 2002, 62 (1) 81-89; DOI: https://doi.org/10.1124/mol.62.1.81

  10. Minto, Lynne

    1. The Effect of Thiopurine Methyltransferase Expression on Sensitivity to Thiopurine Drugs
      Sally A. Coulthard, Linda A. Hogarth, Margaret Little, Elizabeth C. Matheson, Christopher P. F. Redfern, Lynne Minto and Andrew G. Hall
      Molecular Pharmacology July 2002, 62 (1) 102-109; DOI: https://doi.org/10.1124/mol.62.1.102

  11. Miwa, Soichi

    1. Molecular Mechanisms for the Activation of Voltage-Independent Ca2+ Channels by Endothelin-1 in Chinese Hamster Ovary Cells Stably Expressing Human EndothelinA Receptors
      Yoshifumi Kawanabe, Yasuo Okamoto, Soichi Miwa, Nobuo Hashimoto and Tomoh Masaki
      Molecular Pharmacology July 2002, 62 (1) 75-80; DOI: https://doi.org/10.1124/mol.62.1.75

  12. Monsma, Frederick J.

    1. Molecular Modeling and Site-Specific Mutagenesis of the Histamine-Binding Site of the Histamine H4 Receptor
      Niu Shin, Elizabeth Coates, Nicholas J. Murgolo, Kelley L. Morse, Marvin Bayne, Catherine D. Strader and Frederick J. Monsma
      Molecular Pharmacology July 2002, 62 (1) 38-47; DOI: https://doi.org/10.1124/mol.62.1.38

  13. Morcillo, M. José

    1. Design, Synthesis and Pharmacological Evaluation of 5-Hydroxytryptamine1a Receptor Ligands to Explore the Three-Dimensional Structure of the Receptor
      Marı́a L. López-Rodrı́guez, Bruno Vicente, Xavier Deupi, Sergio Barrondo, Mireia Olivella, M. José Morcillo, Bellinda Behamú, Juan A. Ballesteros, Joan Sallés and Leonardo Pardo
      Molecular Pharmacology July 2002, 62 (1) 15-21; DOI: https://doi.org/10.1124/mol.62.1.15

  14. Morse, Kelley L.

    1. Molecular Modeling and Site-Specific Mutagenesis of the Histamine-Binding Site of the Histamine H4 Receptor
      Niu Shin, Elizabeth Coates, Nicholas J. Murgolo, Kelley L. Morse, Marvin Bayne, Catherine D. Strader and Frederick J. Monsma
      Molecular Pharmacology July 2002, 62 (1) 38-47; DOI: https://doi.org/10.1124/mol.62.1.38

  15. Murgolo, Nicholas J.

    1. Molecular Modeling and Site-Specific Mutagenesis of the Histamine-Binding Site of the Histamine H4 Receptor
      Niu Shin, Elizabeth Coates, Nicholas J. Murgolo, Kelley L. Morse, Marvin Bayne, Catherine D. Strader and Frederick J. Monsma
      Molecular Pharmacology July 2002, 62 (1) 38-47; DOI: https://doi.org/10.1124/mol.62.1.38

N

  1. Nakajima, Terumi

    1. Novel Tarantula Toxins for Subtypes of Voltage-Dependent Potassium Channels in the Kv2 and Kv4 Subfamilies
      Pierre Escoubas, Sylvie Diochot, Marie-Louise Célérier, Terumi Nakajima and Michel Lazdunski
      Molecular Pharmacology July 2002, 62 (1) 48-57; DOI: https://doi.org/10.1124/mol.62.1.48

  2. Naylor, Stephen

    1. Activation of the Antitumor Agent Aminoflavone (NSC 686288) Is Mediated by Induction of Tumor Cell Cytochrome P450 1A1/1A2
      Mary J. Kuffel, Jennifer C. Schroeder, Lori J. Pobst, Stephen Naylor, Joel M. Reid, Scott H. Kaufmann and Matthew M. Ames
      Molecular Pharmacology July 2002, 62 (1) 143-153; DOI: https://doi.org/10.1124/mol.62.1.143

  3. Nicolás, Francisco J.

    1. SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
      Gareth J. Inman, Francisco J. Nicolás, James F. Callahan, John D. Harling, Laramie M. Gaster, Alastair D. Reith, Nicholas J. Laping and Caroline S. Hill
      Molecular Pharmacology July 2002, 62 (1) 65-74; DOI: https://doi.org/10.1124/mol.62.1.65

O

  1. Ohshiro, Naomi

    1. Isolation, Characterization and Differential Gene Expression of Multispecific Organic Anion Transporter 2 in Mice
      Yasuna Kobayashi, Naomi Ohshiro, Akiko Shibusawa, Tadanori Sasaki, Shogo Tokuyama, Takashi Sekine, Hitoshi Endou and Toshinori Yamamoto
      Molecular Pharmacology July 2002, 62 (1) 7-14; DOI: https://doi.org/10.1124/mol.62.1.7

  2. Okamoto, Yasuo

    1. Molecular Mechanisms for the Activation of Voltage-Independent Ca2+ Channels by Endothelin-1 in Chinese Hamster Ovary Cells Stably Expressing Human EndothelinA Receptors
      Yoshifumi Kawanabe, Yasuo Okamoto, Soichi Miwa, Nobuo Hashimoto and Tomoh Masaki
      Molecular Pharmacology July 2002, 62 (1) 75-80; DOI: https://doi.org/10.1124/mol.62.1.75

  3. Olivella, Mireia

    1. Design, Synthesis and Pharmacological Evaluation of 5-Hydroxytryptamine1a Receptor Ligands to Explore the Three-Dimensional Structure of the Receptor
      Marı́a L. López-Rodrı́guez, Bruno Vicente, Xavier Deupi, Sergio Barrondo, Mireia Olivella, M. José Morcillo, Bellinda Behamú, Juan A. Ballesteros, Joan Sallés and Leonardo Pardo
      Molecular Pharmacology July 2002, 62 (1) 15-21; DOI: https://doi.org/10.1124/mol.62.1.15

  4. Olson, B. A.

    1. Inhibition of Transforming Growth Factor (TGF)-β1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF-β Type I Receptor Kinase Activity: SB-431542
      N. J. Laping, E. Grygielko, A. Mathur, S. Butter, J. Bomberger, C. Tweed, W. Martin, J. Fornwald, R. Lehr, J. Harling, L. Gaster, J. F. Callahan and B. A. Olson
      Molecular Pharmacology July 2002, 62 (1) 58-64; DOI: https://doi.org/10.1124/mol.62.1.58

  5. Osawa, Yoichi

    1. Alteration of the Heme Prosthetic Group of Neuronal Nitric-Oxide Synthase during Inactivation byN G-Amino-l-arginine in Vitro and in Vivo
      Jennifer L. Vuletich, Ezra R. Lowe, Suree Jianmongkol, Yasuhiko Kamada, Ute M. Kent, Andrew T. Bender, Damon R. Demady, Paul F. Hollenberg and Yoichi Osawa
      Molecular Pharmacology July 2002, 62 (1) 110-118; DOI: https://doi.org/10.1124/mol.62.1.110

  6. Oxford, Gerry S.

    1. Classic D1 Dopamine Receptor AntagonistR-(+)-7-Chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride (SCH23390) Directly Inhibits G Protein-Coupled Inwardly Rectifying Potassium Channels
      Eldo V. Kuzhikandathil and Gerry S. Oxford
      Molecular Pharmacology July 2002, 62 (1) 119-126; DOI: https://doi.org/10.1124/mol.62.1.119

P

  1. Padanilam, Beena A.

    1. Molecular Determinants of Intracellular pH Modulation of Human Kv1.4 N-Type Inactivation
      Benzy J. Padanilam, Tong Lu, Toshinori Hoshi, Beena A. Padanilam, Erwin F. Shibata and Hon-Chi Lee
      Molecular Pharmacology July 2002, 62 (1) 127-134; DOI: https://doi.org/10.1124/mol.62.1.127

  2. Padanilam, Benzy J.

    1. Molecular Determinants of Intracellular pH Modulation of Human Kv1.4 N-Type Inactivation
      Benzy J. Padanilam, Tong Lu, Toshinori Hoshi, Beena A. Padanilam, Erwin F. Shibata and Hon-Chi Lee
      Molecular Pharmacology July 2002, 62 (1) 127-134; DOI: https://doi.org/10.1124/mol.62.1.127

  3. Pardo, Leonardo

    1. Design, Synthesis and Pharmacological Evaluation of 5-Hydroxytryptamine1a Receptor Ligands to Explore the Three-Dimensional Structure of the Receptor
      Marı́a L. López-Rodrı́guez, Bruno Vicente, Xavier Deupi, Sergio Barrondo, Mireia Olivella, M. José Morcillo, Bellinda Behamú, Juan A. Ballesteros, Joan Sallés and Leonardo Pardo
      Molecular Pharmacology July 2002, 62 (1) 15-21; DOI: https://doi.org/10.1124/mol.62.1.15

  4. Pobst, Lori J.

    1. Activation of the Antitumor Agent Aminoflavone (NSC 686288) Is Mediated by Induction of Tumor Cell Cytochrome P450 1A1/1A2
      Mary J. Kuffel, Jennifer C. Schroeder, Lori J. Pobst, Stephen Naylor, Joel M. Reid, Scott H. Kaufmann and Matthew M. Ames
      Molecular Pharmacology July 2002, 62 (1) 143-153; DOI: https://doi.org/10.1124/mol.62.1.143

  5. Proost, Paul

    1. The Unique Property of the CC Chemokine Regakine-1 to Synergize with Other Plasma-Derived Inflammatory Mediators in Neutrophil Chemotaxis Does Not Reside in Its NH2-Terminal Structure
      Mieke Gouwy, Sofie Struyf, Frank Mahieu, Willy Put, Paul Proost and Jo Van Damme
      Molecular Pharmacology July 2002, 62 (1) 173-180; DOI: https://doi.org/10.1124/mol.62.1.173

  6. Put, Willy

    1. The Unique Property of the CC Chemokine Regakine-1 to Synergize with Other Plasma-Derived Inflammatory Mediators in Neutrophil Chemotaxis Does Not Reside in Its NH2-Terminal Structure
      Mieke Gouwy, Sofie Struyf, Frank Mahieu, Willy Put, Paul Proost and Jo Van Damme
      Molecular Pharmacology July 2002, 62 (1) 173-180; DOI: https://doi.org/10.1124/mol.62.1.173

Q

  1. Qian, Ting

    1. Inhibition of the Mitochondrial Permeability Transition by the Nonimmunosuppressive Cyclosporin Derivative NIM811
      Peter C. Waldmeier, Jean-Jacques Feldtrauer, Ting Qian and John J. Lemasters
      Molecular Pharmacology July 2002, 62 (1) 22-29; DOI: https://doi.org/10.1124/mol.62.1.22

  2. Quigley, Sean D.

    1. Co-Regulation of CYP3A4 and CYP3A5 and Contribution to Hepatic and Intestinal Midazolam Metabolism
      Yvonne S. Lin, Amy L. S. Dowling, Sean D. Quigley, Federico M. Farin, Jiong Zhang, Jatinder Lamba, Erin G. Schuetz and Kenneth E. Thummel
      Molecular Pharmacology July 2002, 62 (1) 162-172; DOI: https://doi.org/10.1124/mol.62.1.162

R

  1. Redfern, Christopher P. F.

    1. The Effect of Thiopurine Methyltransferase Expression on Sensitivity to Thiopurine Drugs
      Sally A. Coulthard, Linda A. Hogarth, Margaret Little, Elizabeth C. Matheson, Christopher P. F. Redfern, Lynne Minto and Andrew G. Hall
      Molecular Pharmacology July 2002, 62 (1) 102-109; DOI: https://doi.org/10.1124/mol.62.1.102

  2. Reid, Joel M.

    1. Activation of the Antitumor Agent Aminoflavone (NSC 686288) Is Mediated by Induction of Tumor Cell Cytochrome P450 1A1/1A2
      Mary J. Kuffel, Jennifer C. Schroeder, Lori J. Pobst, Stephen Naylor, Joel M. Reid, Scott H. Kaufmann and Matthew M. Ames
      Molecular Pharmacology July 2002, 62 (1) 143-153; DOI: https://doi.org/10.1124/mol.62.1.143

  3. Reith, Alastair D.

    1. SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
      Gareth J. Inman, Francisco J. Nicolás, James F. Callahan, John D. Harling, Laramie M. Gaster, Alastair D. Reith, Nicholas J. Laping and Caroline S. Hill
      Molecular Pharmacology July 2002, 62 (1) 65-74; DOI: https://doi.org/10.1124/mol.62.1.65

S

  1. Sallés, Joan

    1. Design, Synthesis and Pharmacological Evaluation of 5-Hydroxytryptamine1a Receptor Ligands to Explore the Three-Dimensional Structure of the Receptor
      Marı́a L. López-Rodrı́guez, Bruno Vicente, Xavier Deupi, Sergio Barrondo, Mireia Olivella, M. José Morcillo, Bellinda Behamú, Juan A. Ballesteros, Joan Sallés and Leonardo Pardo
      Molecular Pharmacology July 2002, 62 (1) 15-21; DOI: https://doi.org/10.1124/mol.62.1.15

  2. Sasaki, Tadanori

    1. Isolation, Characterization and Differential Gene Expression of Multispecific Organic Anion Transporter 2 in Mice
      Yasuna Kobayashi, Naomi Ohshiro, Akiko Shibusawa, Tadanori Sasaki, Shogo Tokuyama, Takashi Sekine, Hitoshi Endou and Toshinori Yamamoto
      Molecular Pharmacology July 2002, 62 (1) 7-14; DOI: https://doi.org/10.1124/mol.62.1.7

  3. Schann, Stephan

    1. [125I]2-(2-Chloro-4-iodo-phenylamino)-5-methyl-pyrroline (LNP 911), a High-Affinity Radioligand Selective for I1Imidazoline Receptors
      Hugues Greney, Dragan Urosevic, Stephan Schann, Laurence Dupuy, Véronique Bruban, Jean-Daniel Ehrhardt, Pascal Bousquet and Monique Dontenwill
      Molecular Pharmacology July 2002, 62 (1) 181-191; DOI: https://doi.org/10.1124/mol.62.1.181

  4. Schroeder, Jennifer C.

    1. Activation of the Antitumor Agent Aminoflavone (NSC 686288) Is Mediated by Induction of Tumor Cell Cytochrome P450 1A1/1A2
      Mary J. Kuffel, Jennifer C. Schroeder, Lori J. Pobst, Stephen Naylor, Joel M. Reid, Scott H. Kaufmann and Matthew M. Ames
      Molecular Pharmacology July 2002, 62 (1) 143-153; DOI: https://doi.org/10.1124/mol.62.1.143

  5. Schuetz, Erin G.

    1. Co-Regulation of CYP3A4 and CYP3A5 and Contribution to Hepatic and Intestinal Midazolam Metabolism
      Yvonne S. Lin, Amy L. S. Dowling, Sean D. Quigley, Federico M. Farin, Jiong Zhang, Jatinder Lamba, Erin G. Schuetz and Kenneth E. Thummel
      Molecular Pharmacology July 2002, 62 (1) 162-172; DOI: https://doi.org/10.1124/mol.62.1.162

  6. Schwartz, Thue W.

    1. NK1 Receptor Fused to β-Arrestin Displays a Single-Component, High-Affinity Molecular Phenotype
      Lene Martini, Hanne Hastrup, Birgitte Holst, Alberto Fraile-Ramos, Mark Marsh and Thue W. Schwartz
      Molecular Pharmacology July 2002, 62 (1) 30-37; DOI: https://doi.org/10.1124/mol.62.1.30

  7. Sekine, Takashi

    1. Isolation, Characterization and Differential Gene Expression of Multispecific Organic Anion Transporter 2 in Mice
      Yasuna Kobayashi, Naomi Ohshiro, Akiko Shibusawa, Tadanori Sasaki, Shogo Tokuyama, Takashi Sekine, Hitoshi Endou and Toshinori Yamamoto
      Molecular Pharmacology July 2002, 62 (1) 7-14; DOI: https://doi.org/10.1124/mol.62.1.7

  8. Shibata, Erwin F.

    1. Molecular Determinants of Intracellular pH Modulation of Human Kv1.4 N-Type Inactivation
      Benzy J. Padanilam, Tong Lu, Toshinori Hoshi, Beena A. Padanilam, Erwin F. Shibata and Hon-Chi Lee
      Molecular Pharmacology July 2002, 62 (1) 127-134; DOI: https://doi.org/10.1124/mol.62.1.127

  9. Shibusawa, Akiko

    1. Isolation, Characterization and Differential Gene Expression of Multispecific Organic Anion Transporter 2 in Mice
      Yasuna Kobayashi, Naomi Ohshiro, Akiko Shibusawa, Tadanori Sasaki, Shogo Tokuyama, Takashi Sekine, Hitoshi Endou and Toshinori Yamamoto
      Molecular Pharmacology July 2002, 62 (1) 7-14; DOI: https://doi.org/10.1124/mol.62.1.7

  10. Shin, Niu

    1. Molecular Modeling and Site-Specific Mutagenesis of the Histamine-Binding Site of the Histamine H4 Receptor
      Niu Shin, Elizabeth Coates, Nicholas J. Murgolo, Kelley L. Morse, Marvin Bayne, Catherine D. Strader and Frederick J. Monsma
      Molecular Pharmacology July 2002, 62 (1) 38-47; DOI: https://doi.org/10.1124/mol.62.1.38

  11. Soltysiak, Kelly A.

    1. Selective Allosteric Enhancement of Agonist Binding and Function at Human A3 Adenosine Receptors by a Series of Imidazoquinoline Derivatives
      Zhan-Guo Gao, Seong Gon Kim, Kelly A. Soltysiak, Neli Melman, Adriaan P. IJzerman and Kenneth A. Jacobson
      Molecular Pharmacology July 2002, 62 (1) 81-89; DOI: https://doi.org/10.1124/mol.62.1.81

  12. Strader, Catherine D.

    1. Molecular Modeling and Site-Specific Mutagenesis of the Histamine-Binding Site of the Histamine H4 Receptor
      Niu Shin, Elizabeth Coates, Nicholas J. Murgolo, Kelley L. Morse, Marvin Bayne, Catherine D. Strader and Frederick J. Monsma
      Molecular Pharmacology July 2002, 62 (1) 38-47; DOI: https://doi.org/10.1124/mol.62.1.38

  13. Struyf, Sofie

    1. The Unique Property of the CC Chemokine Regakine-1 to Synergize with Other Plasma-Derived Inflammatory Mediators in Neutrophil Chemotaxis Does Not Reside in Its NH2-Terminal Structure
      Mieke Gouwy, Sofie Struyf, Frank Mahieu, Willy Put, Paul Proost and Jo Van Damme
      Molecular Pharmacology July 2002, 62 (1) 173-180; DOI: https://doi.org/10.1124/mol.62.1.173

T

  1. Thummel, Kenneth E.

    1. Co-Regulation of CYP3A4 and CYP3A5 and Contribution to Hepatic and Intestinal Midazolam Metabolism
      Yvonne S. Lin, Amy L. S. Dowling, Sean D. Quigley, Federico M. Farin, Jiong Zhang, Jatinder Lamba, Erin G. Schuetz and Kenneth E. Thummel
      Molecular Pharmacology July 2002, 62 (1) 162-172; DOI: https://doi.org/10.1124/mol.62.1.162

  2. Tokuyama, Shogo

    1. Isolation, Characterization and Differential Gene Expression of Multispecific Organic Anion Transporter 2 in Mice
      Yasuna Kobayashi, Naomi Ohshiro, Akiko Shibusawa, Tadanori Sasaki, Shogo Tokuyama, Takashi Sekine, Hitoshi Endou and Toshinori Yamamoto
      Molecular Pharmacology July 2002, 62 (1) 7-14; DOI: https://doi.org/10.1124/mol.62.1.7

  3. Treistman, Steven N.

    1. Integrated Channel Plasticity Contributes to Alcohol Tolerance in Neurohypophysial Terminals
      Thomas K. Knott, Alejandro M. Dopico, Govindan Dayanithi, José Lemos and Steven N. Treistman
      Molecular Pharmacology July 2002, 62 (1) 135-142; DOI: https://doi.org/10.1124/mol.62.1.135

  4. Tsi, Chin-Ju

    1. Aurintricarboxylic Acid Protects against Cell Death Caused by Lipopolysaccharide in Macrophages by Decreasing Inducible Nitric-Oxide Synthase Induction via IκB Kinase, Extracellular Signal-Regulated Kinase, and p38 Mitogen-Activated Protein Kinase Inhibition
      Chin-Ju Tsi, Yee Chao, Ching-Wen Chen and Wan Wan Lin
      Molecular Pharmacology July 2002, 62 (1) 90-101; DOI: https://doi.org/10.1124/mol.62.1.90

  5. Tweed, C.

    1. Inhibition of Transforming Growth Factor (TGF)-β1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF-β Type I Receptor Kinase Activity: SB-431542
      N. J. Laping, E. Grygielko, A. Mathur, S. Butter, J. Bomberger, C. Tweed, W. Martin, J. Fornwald, R. Lehr, J. Harling, L. Gaster, J. F. Callahan and B. A. Olson
      Molecular Pharmacology July 2002, 62 (1) 58-64; DOI: https://doi.org/10.1124/mol.62.1.58

U

  1. Urosevic, Dragan

    1. [125I]2-(2-Chloro-4-iodo-phenylamino)-5-methyl-pyrroline (LNP 911), a High-Affinity Radioligand Selective for I1Imidazoline Receptors
      Hugues Greney, Dragan Urosevic, Stephan Schann, Laurence Dupuy, Véronique Bruban, Jean-Daniel Ehrhardt, Pascal Bousquet and Monique Dontenwill
      Molecular Pharmacology July 2002, 62 (1) 181-191; DOI: https://doi.org/10.1124/mol.62.1.181

V

  1. Van Damme, Jo

    1. The Unique Property of the CC Chemokine Regakine-1 to Synergize with Other Plasma-Derived Inflammatory Mediators in Neutrophil Chemotaxis Does Not Reside in Its NH2-Terminal Structure
      Mieke Gouwy, Sofie Struyf, Frank Mahieu, Willy Put, Paul Proost and Jo Van Damme
      Molecular Pharmacology July 2002, 62 (1) 173-180; DOI: https://doi.org/10.1124/mol.62.1.173

  2. Vicente, Bruno

    1. Design, Synthesis and Pharmacological Evaluation of 5-Hydroxytryptamine1a Receptor Ligands to Explore the Three-Dimensional Structure of the Receptor
      Marı́a L. López-Rodrı́guez, Bruno Vicente, Xavier Deupi, Sergio Barrondo, Mireia Olivella, M. José Morcillo, Bellinda Behamú, Juan A. Ballesteros, Joan Sallés and Leonardo Pardo
      Molecular Pharmacology July 2002, 62 (1) 15-21; DOI: https://doi.org/10.1124/mol.62.1.15

  3. Vuletich, Jennifer L.

    1. Alteration of the Heme Prosthetic Group of Neuronal Nitric-Oxide Synthase during Inactivation byN G-Amino-l-arginine in Vitro and in Vivo
      Jennifer L. Vuletich, Ezra R. Lowe, Suree Jianmongkol, Yasuhiko Kamada, Ute M. Kent, Andrew T. Bender, Damon R. Demady, Paul F. Hollenberg and Yoichi Osawa
      Molecular Pharmacology July 2002, 62 (1) 110-118; DOI: https://doi.org/10.1124/mol.62.1.110

W

  1. Waldmeier, Peter C.

    1. Inhibition of the Mitochondrial Permeability Transition by the Nonimmunosuppressive Cyclosporin Derivative NIM811
      Peter C. Waldmeier, Jean-Jacques Feldtrauer, Ting Qian and John J. Lemasters
      Molecular Pharmacology July 2002, 62 (1) 22-29; DOI: https://doi.org/10.1124/mol.62.1.22

Y

  1. Yamamoto, Toshinori

    1. Isolation, Characterization and Differential Gene Expression of Multispecific Organic Anion Transporter 2 in Mice
      Yasuna Kobayashi, Naomi Ohshiro, Akiko Shibusawa, Tadanori Sasaki, Shogo Tokuyama, Takashi Sekine, Hitoshi Endou and Toshinori Yamamoto
      Molecular Pharmacology July 2002, 62 (1) 7-14; DOI: https://doi.org/10.1124/mol.62.1.7

Z

  1. Zhang, Jiong

    1. Co-Regulation of CYP3A4 and CYP3A5 and Contribution to Hepatic and Intestinal Midazolam Metabolism
      Yvonne S. Lin, Amy L. S. Dowling, Sean D. Quigley, Federico M. Farin, Jiong Zhang, Jatinder Lamba, Erin G. Schuetz and Kenneth E. Thummel
      Molecular Pharmacology July 2002, 62 (1) 162-172; DOI: https://doi.org/10.1124/mol.62.1.162
Back to top

In this issue